Stay updated on LANRA + Gilteritinib in FLT3+ R/R AML Clinical Trial
Sign up to get notified when there's something new on the LANRA + Gilteritinib in FLT3+ R/R AML Clinical Trial page.

Latest updates to the LANRA + Gilteritinib in FLT3+ R/R AML Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedFooter updated to Revision: v3.3.3 and removal of HHS Vulnerability Disclosure; no core study information or functions were changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check22 days agoNo Change Detected
- Check43 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2 on the page, indicating a site UI revision. This change does not modify any study data or historical records.SummaryDifference0.1%

- Check50 days agoChange DetectedRemoved the footer notice about government funding and operating status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check64 days agoChange DetectedNew entries have been added to the Record History, showing updated study status and recruitment information.SummaryDifference0.1%

- Check93 days agoChange Detected- Added a government operations notice and operating details, plus a new v3.2.0 revision. - Removed the previous v3.1.0 revision.SummaryDifference11%

- Check101 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.3%

Stay in the know with updates to LANRA + Gilteritinib in FLT3+ R/R AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LANRA + Gilteritinib in FLT3+ R/R AML Clinical Trial page.